AU1168495A - Chemical compounds - Google Patents
Chemical compoundsInfo
- Publication number
- AU1168495A AU1168495A AU11684/95A AU1168495A AU1168495A AU 1168495 A AU1168495 A AU 1168495A AU 11684/95 A AU11684/95 A AU 11684/95A AU 1168495 A AU1168495 A AU 1168495A AU 1168495 A AU1168495 A AU 1168495A
- Authority
- AU
- Australia
- Prior art keywords
- chemical compounds
- compounds
- chemical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/91—Polymers modified by chemical after-treatment
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
- C08G65/33303—Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing amino group
- C08G65/33306—Polymers modified by chemical after-treatment with organic compounds containing nitrogen containing amino group acyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Polyethers (AREA)
- Polyamides (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77979891A | 1991-10-21 | 1991-10-21 | |
| US779798 | 1991-10-21 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU27183/92A Division AU658231B2 (en) | 1991-10-21 | 1992-10-20 | Conjugation of polymer to polypeptide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU1168495A true AU1168495A (en) | 1995-06-01 |
| AU668841B2 AU668841B2 (en) | 1996-05-16 |
Family
ID=25117605
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU27183/92A Expired AU658231B2 (en) | 1991-10-21 | 1992-10-20 | Conjugation of polymer to polypeptide |
| AU11684/95A Expired AU668841B2 (en) | 1991-10-21 | 1995-02-10 | Chemical compounds |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU27183/92A Expired AU658231B2 (en) | 1991-10-21 | 1992-10-20 | Conjugation of polymer to polypeptide |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0539167A3 (en) |
| JP (2) | JP3342060B2 (en) |
| KR (1) | KR100233777B1 (en) |
| AU (2) | AU658231B2 (en) |
| CA (1) | CA2080891A1 (en) |
| FI (1) | FI924747A (en) |
| NO (2) | NO924060L (en) |
| NZ (1) | NZ244778A (en) |
| ZA (1) | ZA928099B (en) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6565841B1 (en) | 1991-03-15 | 2003-05-20 | Amgen, Inc. | Pulmonary administration of granulocyte colony stimulating factor |
| US5298643A (en) * | 1992-12-22 | 1994-03-29 | Enzon, Inc. | Aryl imidate activated polyalkylene oxides |
| US5349001A (en) * | 1993-01-19 | 1994-09-20 | Enzon, Inc. | Cyclic imide thione activated polyalkylene oxides |
| GB9317618D0 (en) * | 1993-08-24 | 1993-10-06 | Royal Free Hosp School Med | Polymer modifications |
| US5919455A (en) | 1993-10-27 | 1999-07-06 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
| US5643575A (en) * | 1993-10-27 | 1997-07-01 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
| US5795569A (en) * | 1994-03-31 | 1998-08-18 | Amgen Inc. | Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation |
| EP0755263A4 (en) * | 1994-03-31 | 2005-02-09 | Amgen Inc | Compositions and methods for stimulating megakaryocyte growth and differentiation |
| US5730990A (en) * | 1994-06-24 | 1998-03-24 | Enzon, Inc. | Non-antigenic amine derived polymers and polymer conjugates |
| US20030053982A1 (en) | 1994-09-26 | 2003-03-20 | Kinstler Olaf B. | N-terminally chemically modified protein compositions and methods |
| US5824784A (en) | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
| CA2204726A1 (en) * | 1994-11-09 | 1996-12-27 | Robin E. Offord | Functionalized polymers for site-specific attachment |
| US5770577A (en) * | 1994-11-14 | 1998-06-23 | Amgen Inc. | BDNF and NT-3 polypeptides selectively linked to polyethylene glycol |
| JP2001508783A (en) * | 1997-01-29 | 2001-07-03 | ポリマスク・ファーマシューティカルズ・パブリック・リミテッド・カンパニー | PEGylation method |
| US6423685B1 (en) | 1998-03-05 | 2002-07-23 | Chiron Corporation | Method for increasing the serum half-life of a biologically active molecule |
| US6420339B1 (en) | 1998-10-14 | 2002-07-16 | Amgen Inc. | Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility |
| HU228582B1 (en) | 1998-10-23 | 2013-04-29 | Kirin Amgen Inc | Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity |
| JP4670150B2 (en) * | 1999-04-02 | 2011-04-13 | 味の素株式会社 | Method for producing subunit peptides derived from multimeric proteins |
| DK1311285T4 (en) | 2000-05-15 | 2017-07-24 | Hoffmann La Roche | Liquid pharmaceutical composition containing an erythropoietin derivative |
| JP2006515161A (en) * | 2002-08-09 | 2006-05-25 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング | T cell epitope of erythropoietin |
| US7459435B2 (en) | 2002-08-29 | 2008-12-02 | Hoffmann-La Roche Inc. | Treatment of disturbances of iron distribution |
| US7459436B2 (en) | 2002-11-22 | 2008-12-02 | Hoffmann-La Roche Inc. | Treatment of disturbances of iron distribution |
| GEP20084486B (en) * | 2002-12-26 | 2008-09-25 | Mountain View Pharmaceuticals | Polymer conjugates of interferon-beta with enhanced biological potency |
| US7074755B2 (en) | 2003-05-17 | 2006-07-11 | Centocor, Inc. | Erythropoietin conjugate compounds with extended half-lives |
| JP2007537986A (en) | 2003-05-30 | 2007-12-27 | セントカー・インコーポレーテツド | Formation of a novel erythropoietin complex using transglutaminase |
| DE10358213A1 (en) * | 2003-12-12 | 2005-07-28 | Clariant Gmbh | Polyethylene glycol and its preparation |
| PL1696947T3 (en) | 2003-12-19 | 2014-08-29 | Hoffmann La Roche | Use of erythropoietin in the treatment of disturbances of iron distribution in chronic inflammatory intestinal diseases |
| US8143380B2 (en) | 2004-07-08 | 2012-03-27 | Amgen Inc. | Therapeutic peptides |
| US20090042790A1 (en) * | 2005-06-13 | 2009-02-12 | Nastech Pharmaceutical Company Inc. | Transmucosal delivery of peptide derivatives |
| US9283260B2 (en) | 2006-04-21 | 2016-03-15 | Amgen Inc. | Lyophilized therapeutic peptibody formulations |
| CN101357986B (en) * | 2007-06-13 | 2013-06-05 | 康达医药科技有限公司 | Polyethylene glycol functional derivatives and manufacturing method thereof |
| JP5497449B2 (en) * | 2007-11-28 | 2014-05-21 | 富士フイルム株式会社 | Chemical modification methods for biopolymers and polypeptides |
| CN101455844B (en) * | 2007-12-10 | 2011-09-14 | 江苏豪森药业股份有限公司 | PEG-erythrocyte-stimulating factor and preparation method and use thereof |
| PT2621519T (en) | 2010-09-28 | 2017-10-04 | Aegerion Pharmaceuticals Inc | Leptin-abd fusion polypeptides with enhanced duration of action |
| CN116515120B (en) * | 2023-06-07 | 2024-01-26 | 中石油(上海)新材料研究院有限公司 | Polyamide elastomer containing triazine ring and preparation method thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4847325A (en) * | 1988-01-20 | 1989-07-11 | Cetus Corporation | Conjugation of polymer to colony stimulating factor-1 |
| WO1990006128A1 (en) * | 1988-12-05 | 1990-06-14 | Biogen, Inc. | Methods and compositions for inhibiting platelet aggregation |
| WO1992016555A1 (en) * | 1991-03-18 | 1992-10-01 | Enzon, Inc. | Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers |
-
1992
- 1992-10-16 NZ NZ244778A patent/NZ244778A/en not_active IP Right Cessation
- 1992-10-19 CA CA002080891A patent/CA2080891A1/en not_active Abandoned
- 1992-10-19 KR KR1019920019174A patent/KR100233777B1/en not_active IP Right Cessation
- 1992-10-20 JP JP30626292A patent/JP3342060B2/en not_active Expired - Lifetime
- 1992-10-20 NO NO92924060A patent/NO924060L/en unknown
- 1992-10-20 ZA ZA928099A patent/ZA928099B/en unknown
- 1992-10-20 EP EP19920309583 patent/EP0539167A3/en not_active Withdrawn
- 1992-10-20 AU AU27183/92A patent/AU658231B2/en not_active Expired
- 1992-10-20 FI FI924747A patent/FI924747A/en not_active Application Discontinuation
-
1995
- 1995-02-10 AU AU11684/95A patent/AU668841B2/en not_active Expired
-
1997
- 1997-03-10 NO NO971085A patent/NO971085D0/en unknown
-
2002
- 2002-05-24 JP JP2002151245A patent/JP2003012697A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU668841B2 (en) | 1996-05-16 |
| JPH05214092A (en) | 1993-08-24 |
| KR100233777B1 (en) | 1999-12-01 |
| JP3342060B2 (en) | 2002-11-05 |
| NO924060D0 (en) | 1992-10-20 |
| KR930008017A (en) | 1993-05-20 |
| ZA928099B (en) | 1994-04-20 |
| EP0539167A3 (en) | 1993-08-04 |
| FI924747A (en) | 1993-04-22 |
| EP0539167A2 (en) | 1993-04-28 |
| NZ244778A (en) | 1994-03-25 |
| NO924060L (en) | 1993-04-22 |
| CA2080891A1 (en) | 1993-04-22 |
| NO971085L (en) | 1993-04-22 |
| JP2003012697A (en) | 2003-01-15 |
| FI924747A0 (en) | 1992-10-20 |
| AU658231B2 (en) | 1995-04-06 |
| NO971085D0 (en) | 1997-03-10 |
| AU2718392A (en) | 1993-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1704492A (en) | Chemical compounds | |
| AU1168495A (en) | Chemical compounds | |
| GB9103862D0 (en) | Chemical compounds | |
| GB9105152D0 (en) | Chemical compounds | |
| AU2654792A (en) | Chemical compounds | |
| GB9103770D0 (en) | Chemical compounds | |
| AU2156192A (en) | Chemical compounds | |
| AU1975092A (en) | Compounds | |
| GB9100431D0 (en) | Chemical compounds | |
| AU4604193A (en) | Chemical compound | |
| AU5922994A (en) | Oxazinobenzazole compounds | |
| GB9100637D0 (en) | Chemical compounds | |
| AU2072092A (en) | A87689 compounds | |
| GB9106350D0 (en) | Chemical compounds | |
| GB9104889D0 (en) | Chemical compounds | |
| GB9100438D0 (en) | Chemical compounds | |
| GB9106339D0 (en) | Chemical compounds | |
| GB9100435D0 (en) | Chemical compounds | |
| GB9104888D0 (en) | Chemical compounds | |
| GB9103894D0 (en) | Chemical compounds | |
| GB9107328D0 (en) | Chemical compounds | |
| GB9100419D0 (en) | Chemical compounds | |
| GB9102725D0 (en) | Chemical compounds | |
| GB9102690D0 (en) | Chemical compounds | |
| GB9102188D0 (en) | Chemical compounds |